Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. - Wikidata - wikimedia - TriplyDB

Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases.

Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases.

http://www.wikidata.org/entity/Q30835275

about

A new gamma-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase NRF IRES activity is mediated by RNA binding protein JKTBP1 and a 14-nt RNA element Indoleamine 2,3 dioxygenase in intestinal disease New proteomic approaches for biomarker discovery in inflammatory bowel disease.Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.Anti-obesity sodium tungstate treatment triggers axonal and glial plasticity in hypothalamic feeding centers.Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.Identification of novel genes in intestinal tissue that are regulated after infection with an intestinal nematode parasite Is the variant c.422+90G → A in intron 4 of indoleamine 2, 3 -dioxygenase (IDO) gene related to age related cataracts?Indoleamine 2,3-dioxygenase, tryptophan catabolism, and Mycobacterium avium subsp. paratuberculosis: a model for chronic mycobacterial infections.Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity Genomics and proteomics: implications for inflammatory bowel diseases.Biomarkers in inflammatory bowel disease: current practices and recent advances.Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies.Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective Indoleamine 2,3-dioxygenase and tumor-induced tolerance Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies.New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.Gene expression patterns in experimental colitis in IL-10-deficient mice Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation.Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.The future of molecular approaches to inflammatory bowel disease.Changes in protein expression after treatment with Ancylostoma caninum excretory/secretory products in a mouse model of colitis.Proteomics at the interface of psychology, gut physiology and dysfunction: an underexploited approach that deserves expansion.Immunoprotective role of indoleamine 2,3-dioxygenase in engraftment of allogenic skin substitute in wound healing.Integrated stress response-altered pro-inflammatory signals in mucosal immune-related cells.Proteomics and metabolomics in inflammatory bowel disease.Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.Proteome profiling of spinal cord and dorsal root ganglia in rats with trinitrobenzene sulfonic acid-induced colitis.Update on current applications of proteomic in the study of inflammatory bowel disease.Microbial control of intestinal innate immunity.Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate.Inflamed intestinal mucosa features a specific epithelial expression pattern of indoleamine 2,3-dioxygenase.Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue.Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells.Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.Proteomics Characterization of the Secretome from Rat Pancreatic Stellate Cells with ATP-Binding Cassette Transporters (ABCG2) and NCAM Phenotype

P2860

Q24633859-2991ABA0-62FF-43A3-9C29-DD3E3C5F0308 Q24669986-D7AB828A-7C22-461B-8279-1CC97C2FE4BC Q27025063-BBC90293-6A0F-4B84-8732-F0DC7AB7AF7F Q34096526-A3ACE31B-082F-4AD7-9792-DA56FC713A83 Q34154099-EAD2EBD1-CF87-49D5-9ACD-36F8833F20A9 Q34339605-BC9838D9-C2A0-4705-9E61-88A23663C895 Q34413480-62A23648-8F3B-48BE-A196-87A2EBA6A61B Q34428271-18D6910E-0519-431B-8F94-867CC9471C06 Q34629566-A2E9EEDE-A40D-4702-8325-6CDD5BF6557F Q35191891-2E7AE259-15B5-4EEB-95A8-013C9A7134BA Q35605835-0D997CD4-C4BC-4EB5-910D-AABC24ED4C4E Q35787618-BF147F8D-A549-49B4-85FC-D3D8F49916AF Q35840853-0DBA2D58-8092-4C8D-BDA0-A02997A7F25D Q36155966-FD6B89E1-EEE4-470F-A815-66ECF98FD491 Q36604130-7AF2343D-9DB7-482D-83F0-865BA941F0B8 Q36809762-AE6C9006-5F50-4EF2-8E46-06F742B4BD96 Q37155926-256A0CBC-0406-4552-A906-788D1DCA93B9 Q37206175-BDF23BF8-F146-442A-B62B-C63DE0B70C9E Q37391156-D0161D7A-5D45-4FAB-B5FD-26E273C994D6 Q37424082-008E76B8-3930-4B38-AEA4-4AAA5F41E9DD Q37486151-02FCD261-0DC4-49BE-8C5A-9BCFF01BB52C Q37587990-65AB4F50-AE90-479D-B21A-303590F58AD3 Q37638028-3BBF4774-D937-4B4C-A72F-7A82BEC5336E Q37945789-4B003B6C-355A-40AD-9D6E-FA2D2648C3FC Q37976231-56B22FE0-1C05-4A01-9662-F53D6A31242D Q38067151-E6FC6B43-131F-4294-BEF6-3E20C1587729 Q38089179-0DBB7FB0-4D2E-440B-8F12-4F63BD171375 Q38656159-DFD4E7A4-31E9-4960-8DED-36D489EB8408 Q41928668-1EB6B163-BE97-4907-91F2-A9FAD32B25FF Q42406649-402725CF-2FA8-4AD8-AADA-561F933A3EE9 Q43164213-A9E17197-D552-4ACA-B7B2-6F3A4DA2C732 Q44767287-E885B0B0-DB17-43AD-87F4-CC5586FBFF6D Q46545401-4982B3E7-A8A1-443C-BFF9-3F1AF70072A2 Q46912061-EB3475EA-3412-4675-BE4C-77F94D5D2025 Q54348683-2E91E62B-20D9-493B-ADA2-80CDD9D08826 Q54451070-CADF8EF2-3400-4ED4-83F1-93D4B9377DAB Q58999668-0B524B64-3A49-4740-A6D4-68BF08705705

P2860

Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases.

http://www.wikidata.org/entity/Q30835275

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Proteomic analysis of cytokine ...... r inflammatory bowel diseases.

@ast

Proteomic analysis of cytokine ...... r inflammatory bowel diseases.

@en

type

label

Proteomic analysis of cytokine ...... r inflammatory bowel diseases.

@ast

Proteomic analysis of cytokine ...... r inflammatory bowel diseases.

@en

prefLabel

Proteomic analysis of cytokine ...... r inflammatory bowel diseases.

@ast

Proteomic analysis of cytokine ...... r inflammatory bowel diseases.

@en

P1433

Q30835275-DF770C28-4D7F-4DB7-86E6-8D948527975E

P1476

Q30835275-6D14222A-08C0-4FC0-ABAD-9E213F1920EF

P2093

Q30835275-47B49A1B-AF34-4520-B600-D4802050D931

Q30835275-5DD48FAF-A0EF-4679-9934-4D0D7BD8EC9C

Q30835275-76FAAE49-6E1E-4B28-B1B1-FFB8FDBE513A

Q30835275-BEF8860B-4DB9-4A66-9433-5821CC995055

Q30835275-C6925ADF-EDEC-41BC-9184-318FB5CA09BE

Q30835275-C7B546A9-3D1F-450D-9705-EBB54962E659

Q30835275-C9C5E645-4F26-4C58-8E47-12921BA3BC23

Q30835275-D505F36C-B136-4B23-A821-F03AA57A9B8E

P2860

Q30835275-0923FF2F-59AC-4408-82F9-BA1ABCAEA56F

Q30835275-11072127-CFBF-42B0-ADF4-85D2A10611C3

Q30835275-11869D16-7EEB-4B10-985C-B2AE3CF1ABE9

Q30835275-14656B71-F094-4055-83EB-2F391C264DBA

Q30835275-1D0ABD09-9667-47F2-A6DE-7709BBBCBC67

Q30835275-286681FE-6B90-4635-877B-8CFB8A49183B

Q30835275-4C45510A-0774-4D5E-A758-51643D98879E

Q30835275-5D2C539E-F5DC-46E2-986B-36810B29F7AB

Q30835275-60C48231-8B15-4E62-9C3A-B804757CED4B

Q30835275-624CA29C-11BF-429A-AAE3-768B8BD2D512

P304

Q30835275-BBEFE7BD-ABEF-49F2-899E-F37CBB6CB9EC

P31

Q30835275-A66CAB00-3D23-423F-AA8C-D2D5DE45BBCF

P356

Q30835275-0792BFF2-099C-459E-AC9B-93E6841946F3

P433

Q30835275-3481800E-CAC8-4D93-B5BC-D5FE8BA6D8F9

P478

Q30835275-F6C28C01-AD66-4FB3-B30A-E0E4DF2EFB74

P577

Q30835275-B4CF2627-A234-4DF6-9B07-8E674E826E03

P698

Q30835275-78A67264-C45E-4A12-885D-388873565CE6

P921

Q30835275-948F0B70-FA1F-4453-A078-2B6FADBA8164

Q30835275-DB39B7D2-E473-4349-8DEA-47E8DA7E00BD

P356

1615-9861(200205)2:5%3C551::AID-PROT551%3E3.0.CO;2-O

P1433

P1476

Proteomic analysis of cytokine ...... r inflammatory bowel diseases.

@en

P2093

Catherine Servis

http://www.w3.org/2001/XMLSchema#string

Emanuela Felley-Bosco

http://www.w3.org/2001/XMLSchema#string

Marc Reymond

http://www.w3.org/2001/XMLSchema#string

Muriel André

http://www.w3.org/2001/XMLSchema#string

Nicole Lévy

http://www.w3.org/2001/XMLSchema#string

Osamu Takikawa

http://www.w3.org/2001/XMLSchema#string

Pierre Michetti

http://www.w3.org/2001/XMLSchema#string

Sílvia Barceló-Batllori

http://www.w3.org/2001/XMLSchema#string

P2860

Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling

Interferon-alpha induces nmi-IFP35 heterodimeric complex formation that is affected by the phosphorylation of IFP35

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes

Cloning and characterization of a cDNA encoding a novel heterogeneous nuclear ribonucleoprotein-like protein and its expression in myeloid leukemia cells

Human interferon gamma potently induces the synthesis of a 55-kDa protein (gamma 2) highly homologous to rabbit peptide chain release factor and bovine tryptophanyl-tRNA synthetase

Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease

Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

Conserved structures and diversity of functions of RNA-binding proteins

Inhibition of T cell proliferation by macrophage tryptophan catabolism

P304

551-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1615-9861(200205)2:5<551::AID-PROT551>3.0.CO;2-O

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11987129

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases